Abbotts new coronary imaging software powered by artificial intelligence launched in India

Abbott has launched its new vascular imaging platform powered by Ultreon 1.0 Software in India. This first-of-its-kind intra-vascular imaging software combines optical coherence tomography (OCT) with the power of artificial intelligence (AI) providing physicians a comprehensive view of blood flow and blockages within coronary arteries.
 
The innovative imaging software can automatically differentiate between a calcified and non-calcified blockage, detect the severity of calcium-based blockages and measure vessel diameter. In addition, it helps physicians guide precise stent deployment, ensure optimal stent expansion and apposition with instantaneous display of results to enhance precision during coronary stenting procedures.
 
Unlike traditional imaging methods such as conventional angiography, Abbott’s OCT technology uses near-infrared light to provide high-definition, precise imaging from within a blood vessel, allowing physicians to capture information from even the most complex patient anatomy. The software enables a streamlined workflow that facilitates accurate and faster decision-making, reduces ambiguities to focus on what's most important: caring for the patient and improving their quality of life.
 
With the launch of Ultreon 1.0 Software, Abbott is further leveraging OCT technology to help physicians make better treatment decisions for their patients. Recent data show that physicians altered their treatment strategy in 88% of coronary artery blockages based on new information provided by OCT when used with MLD MAX, a new workflow that helps guide stenting decisions and provide physicians with treatment strategies to optimize stent placement.
 
“This new software for OCT provides us with an automated and comprehensive view of the coronary arteries. This certainly facilitates better decision-making while guiding precision stent placement,” said Dr. Ankur Phatarpekar from Symbiosis Speciality Hospital, Mumbai. “These types of technologies are instrumental in providing the best care for our patients.”
 
In market research commissioned by Abbott titled Beyond Intervention in August 2020, physicians and administrators identified technology as a critical component to improving patient outcomes across the healthcare continuum. According to the research, 83.2% of physicians agreed that advances in diagnostic and treatment technologies, such as OCT, have translated to tangible improvements in patient care.
 
Ultreon Software is an example of technology designed to augment physician decision-making, particularly when combined with established tools providing comprehensive physiological assessment of coronary blood flow and severity of blockages. With the rising burden of cardiovascular diseases in India, it is our constant effort to bring newer technologies into the country, offering physicians the tools needed to provide the highest level of care and best possible outcomes for patients.
 
"Increased adoption of OCT imaging, when combined with advanced technology like AI, allows cardiologists to have a more precise and measurable way of supporting patients undergoing coronary stent procedures," said Tushar Sharma, general manager for Abbott’s vascular business in India and South Asia.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!